It does not compete directly on maximum weight loss with injectable multi-receptor agonists but instead offers a differentiated value proposition based on oral convenience, no restrictions, lower manufacturing costs, and the potential to dramatically expand the addressable patient population for GLP-1 therapy
More severe effects include dehydration because stomach paralysis promotes a feeling of fullness such that you may not want to eat or drink anything at all
GLP-1 medications start with low doses that gradually increase over weeks, meaning the full appetite-suppressing effect takes longer to develop
Svensson is a co-founder of Merrifield Therapeutics
Sermorelin, a growth hormone-releasing hormone (GHRH) analog, stimulates the pituitary through a different pathway, promoting the natural pulsatile release of growth hormone
1,2,3 The caveat is that were comparing trials that werent designed to be compared